Ronald Hansen

Bio

As Senior Associate Dean for Program Development, Ronald Hansen was responsible for Simon’s international program development, undergraduate program and involved in the Technical Entrepreneurship And Management (TEAM) MS and the Technical Entrepreneurship and Management in Biomanufacturing and Therapeutic Development (TEAM-BMTD) programs. He served as area coordinator for the concentrations of Business Environment and Public Policy, Health Sciences Management and International Management. Prior to this position, Ron served as Senior Associate Dean for Faculty and Research for 21 years. He came to the School in 1971 as an assistant professor and became director of the Systems Analysis Program in 1972. From 1977 to 1986, he was the associate director of the Center for Research in Government Policy and Business, now the Bradley Policy Research Center. He briefly left the Simon School to become the first recipient of the Merrell Dow Professorship of Pharmaceutical Administration in the College of Pharmacy at The Ohio State University (1986–88). Hansen is widely recognized for his scholarly research in drug-development policy and in the regulation of the pharmaceutical industry. He helped to establish and collaborates on research with the Tufts Center for the Study of Drug Development. Hansen was on the editorial board of the Journal of Research in Pharmaceutical Economics. He was a member of the National Advisory Council on Health Care Technology Assessment (1985–88) and the Committee on the Children’s Vaccine Initiative, Institute of Medicine, National Academy of Sciences (1992–93). Hansen earned a B.A. degree in mathematics from Northwestern University, and an M.A. degree in economics and a Ph.D. in economics from the University of Chicago.

Teaching Interests

Evolving Medical Markets, Medical Device Development & Marketing, Pharmaceutical Economics, Medical Entrepreneurship, Healthcare Business Models, International Management

Research Interests

Hansen is widely recognized for his scholarly research in drug-development policy and in the regulation of the pharmaceutical industry. He helped to establish and collaborates on research with the Tufts Center for the Study of Drug Development. Hansen was on the editorial board of the Journal of Research in Pharmaceutical Economics. He was a member of the National Advisory Council on Health Care Technology Assessment (1985–88) and the Committee on the Children’s Vaccine Initiative, Institute of Medicine, National Academy of Sciences (1992–93).

Professional History

Clinical Professor Emeritus

University of Rochester Simon Business School

2016 -

William H. Meckling Professor of Business Administration; Sr. Associate Dean for Program Development

University of Rochester Simon Business School, Rochester NY

July 2009 - 2016

Senior Associate Dean for Faculty and Research

University of Rochester Simon School of Business, Rochester NY

July 1999 - June 2009

Associate Dean for Academic Affairs

University of Rochester Simon School of Business, Rochester NY

July 1988 - June 1999

Assocate Professor, Merrel Dow Professorship

Ohio State University College of Pharmacy, Division of Pharmaceutical Administration, Columbus OH

July 1986 - August 1988

Associate Director

Graduate School of Management (renamed William E. Simon Graduate School of Business Administration November 1986), Center for Research in Government Policy and Business (renamed Bradley Policy Research Center November 1987), Rochester NY

June 1977 - July 1986

Visiting Professor of Economics

Colgate-Rochester Divinity, Rochester NY

1980 - 1984

Assisant Professor

University of Rochester Graduate School of Management, Rochester NY

September 1971 - June 1977

University of Western Ontario, London Ontario, Canada

June 1970 - August 1970

Education

University of Chicago - 1982

Ph D

Economics

University of Chicago - 1970

MA

Economics

Northwestern University - 1966

BA

Mathematics

Publications

2016

Innovation in the Pharmaceutical Industry: New Estimates of R&D costs

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Journal of Health Economics

Volume: 47

Visit the website: www.journals.elsevier.com/journal-of-health-economics

2015

The Cost of Drug Development (Letterto the Editor)

Contribution Type: Journal Article, Professional Journal

Journal/Publisher/Proceedings Publisher: New England Journal of Medicine

Volume: 372

Issue: 20

Visit the website: www.nejm.org/

2008

Misleading Congress about Drug Development: Reply

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Journal of Health Politics, Policy and Law/Duke University Press

Volume: 33

Download the PDF: http://www.simon.rochester.edu/faculty_research_pdf/ron.hansen/intellcont/Misleading Congress About Drug Development - Reply (with Dimasi and Grabowski) (JHPPL 2008)-1.pdf

2005

Reply – Extraordinary Claims Require Extraordinary Evidence

Contribution Type: Journal Article, Professional Journal

Journal/Publisher/Proceedings Publisher: Journal of Health Economics/Elsevier

Volume: 24

Issue: 2005

Download the PDF: http://www.simon.rochester.edu/faculty_research_pdf/ron.hansen/intellcont/Reply - Extra Claims Require Extra Evidence-1.pdf

2005

Reply - Setting the Record Straight on Setting the Record Straight: Response to the Light and Warburton Rejoinder

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Journal of Health Economics/Elsevier

Volume: 24

Download the PDF: http://www.simon.rochester.edu/faculty_research_pdf/ron.hansen/intellcont/Reply - Setting the Record Straight-1.pdf

2004

Assessing claims about the cost of new drug development: a critique of the Public Citizen and TB Alliance reports

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Tufts Center for the Study of Drug Development, Tufts University

2003

The Price of Innovation: New Estimates of Drug Development Costs

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Journal of Health Economics/Elsevier

Volume: 22

Download the PDF: http://www.simon.rochester.edu/faculty_research_pdf/ron.hansen/intellcont/Price of Innovation-1.pdf

2000

Regulation of the Pharmaceutical Industry (Book Chapter)

Contribution Type: Book, Chapter in Scholarly Book-New

Journal/Publisher/Proceedings Publisher: American Health Care: Government, Market Processes, and the Public Interest

1996

Costs and Benefits of Cost-Benefit Analysis in Pharmaceutical Promotion and Utilization Decisions,” Chapter 14 in Competitive Strategies in the Pharmaceutical Industry

Contribution Type: Book, Chapter in Non-Scholarly Book-New

Journal/Publisher/Proceedings Publisher: AEI Press

1996

Science and innovation: The US pharmaceutical industry during the 1980s

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Journal of Economic Literature

Volume: 34

Issue: 2

1995

FDA regulation of the pharmaceutical industry

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Hazardous to Our Health? FDA Regulation of Health Care Products

1995

Research And Development Costs For New Drugs By Therapeutic Category: A Study of the US Pharmaceutical Industry

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: PharmcoEconomics / Adis International Ltd

Volume: 7

Issue: 2

Download the PDF: http://www.simon.rochester.edu/faculty_research_pdf/ron.hansen/intellcont/Research and Development Costs for New Drugs by Therapeutic Category (PharmacoEconomics 1995)-1.pdf

1991

Cost of Innovation in the Pharmaceutical Industry

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Journal of Health Economics/Elsevier

Volume: 10

Download the PDF: http://www.simon.rochester.edu/faculty_research_pdf/ron.hansen/intellcont/Cost of Innovation in the Pharm Industry (JHE 1991)-1.pdf

1991

Modeling of Cost Analysis

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Journal of Pharmaceutical Economics

Volume: 1

Issue: 2

1989

Compensation Alternatives for Occupational Disease and Disability

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: The Journal of Risk and Insurance / Wiley

Volume: 56

Issue: 2

Download the PDF: http://www.simon.rochester.edu/faculty_research_pdf/ron.hansen/intellcont/Comp Alternatives for Occupational Disease and Disability (w MacAvoy and Smith) (1989)-1.pdf

1987

Effects of Cost Containment on Pharmaceutical Innovation

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Clinical Research Practices and Drug Regulatory Affairs

Volume: 5

Issue: 5-6

1987

Pharmaceutical Regulation: The Past and Future Twenty-five Years

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Health Economics: Prospects for the Future, Croom Helm, London, England

1984

Success Rate in the United States Drug Development System

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Clinical Pharmacology and Therapeutics

Volume: 36

Issue: 5

Download the PDF: http://www.simon.rochester.edu/faculty_research_pdf/ron.hansen/intellcont/Success Rates in US Drug Development System (1984)-1.pdf

1983

International Issues of Drug Regulation

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: Journal of Institutional and Theoretical Economics

Volume: 139

Issue: 3

Visit the website: www.jstor.org/stable/40750632

1982

Costs and benefits of innovation and regulation in the pharmaceutical industry

Contribution Type: Book, Scholarly-New

Journal/Publisher/Proceedings Publisher: University of Chicago

1979

The pharmaceutical development process: estimates of development costs and times and the effects of proposed regulatory changes

Contribution Type: Book, Scholarly-New

Journal/Publisher/Proceedings Publisher: Center for the Study of Drug Development, Department of Pharmacology and Toxicology, University of Rochester Medical Center

1978

Technological Innovation and Government Regulation of Pharmaceuticals in the United States and Great Britain: Executive Summary

Contribution Type: Book, Scholarly-New

Journal/Publisher/Proceedings Publisher: School of Medicine and Dentistry, Graduate School of Management, University of Rochester

1977

Comments on the proposed change in FDA’s trade secrets policy.

Contribution Type: Journal Article, Academic Journal

Journal/Publisher/Proceedings Publisher: American journal of pharmacy and the sciences supporting public health

Volume: 149

Issue: 5

Current Research Programs

Innovation In The Pharmaceutical Industry: New Estimates of R&D Costs

Resubmitted to JHE in June 2015; Accepted for publication for May 2016.